Related references
Note: Only part of the references are listed.Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures
Cara L. Croft et al.
CELL DEATH & DISEASE (2017)
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss
Sachin Suresh Tiwari et al.
BRAIN (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Dario Tejera et al.
CURRENT ALZHEIMER RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain
Ksenia Kurbatskaya et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Astrocytes and neuroinflammation in Alzheimer's disease
Emma C. Phillips et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease
Jung Min Song et al.
EXPERIMENTAL NEUROLOGY (2014)
Selective alterations of neurons and circuits related to early memory loss in Alzheimer's disease
Maria Llorens-Martin et al.
FRONTIERS IN NEUROANATOMY (2014)
Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology
Beatriz G. Perez-Nievas et al.
BRAIN (2013)
A Tetra(Ethylene Glycol) Derivative of Benzothiazole Aniline Enhances Ras-Mediated Spinogenesis
Andrea Megill et al.
JOURNAL OF NEUROSCIENCE (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
Dynamic association of tau with neuronal membranes is regulated by phosphorylation
Amy M. Pooler et al.
NEUROBIOLOGY OF AGING (2012)
Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation
Olivia A. Shipton et al.
JOURNAL OF NEUROSCIENCE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity
Lila K. Habib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
Natalia Shiryaev et al.
NEUROBIOLOGY OF DISEASE (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
Dick Terwel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease
Yasuji Matsuoka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics
Seongeun Cho et al.
CURRENT NEUROPHARMACOLOGY (2007)
PKA modulates GSK-3β- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners
Fei Liu et al.
FEBS LETTERS (2006)
Oligo(ethylene glycol) derivatives of thioflavin T as inhibitors of protein-amyloid interactions
Petra Inbar et al.
CHEMBIOCHEM (2006)
Staining protocol for organotypic hippocampal slice cultures
Nadine Gogolla et al.
NATURE PROTOCOLS (2006)
Organotypic cultures as tools for functional screening in the CNS
L Sundstrom et al.
DRUG DISCOVERY TODAY (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cdk5, a therapeutic target for Alzheimer's disease?
LH Tsai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing
Y Su et al.
BIOCHEMISTRY (2004)
Synaptic changes in Alzheimer's disease -: Increased amyloid-β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence
KH Gylys et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
S Oddo et al.
NEUROBIOLOGY OF AGING (2003)
Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
